糖尿病脚在风湿性疾病的背景下:病原和治疗方法
Dana Bekaryssova1, Marlen Yessirkepov2,3, Ak-Uke Rakisheva4
1Department of Project Management, South Kazakhstan Medical Academy, Shymkent, Kazakhstan. bekaryssova.da@gmail.com.
Rheumatology international
|May 2, 2025
概括
由于炎症和药物的副作用,糖尿病脚并发症在风湿性疾病中恶化. 针对糖尿病和类风湿病的综合护理对于预防截肢等严重后果至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 内分泌学 在内分泌学.
- 血管医学 血管医学
背景情况:
- 糖尿病脚是糖尿病的主要并发症,导致生活质量下降和截肢风险增加.
- 患有类风湿性疾病的患者因慢性炎症和血管问题而面临糖尿病足的发病率和严重程度较高.
研究的目的:
- 审查糖尿病足的多因素病原性,特别是在患有类风湿性疾病的患者.
- 突出与类风湿性疾病相关的因素和药物对糖尿病足部发育的影响.
- 强调需要采用多学科方法来管理这种复杂的疾病.
主要方法:
- 文献综述研究了糖尿病,风湿性疾病和糖尿病足之间的相互作用.
- 分析病原遗传机制,包括神经病变,血管疾病,炎症和生物机械因素.
- 对药理学药剂在加剧糖尿病足风险中的作用的评估.
主要成果:
- 糖尿病神经病变,周围血管疾病和感染是糖尿病足的关键驱动因素.
- 系统性炎症,血管功能障碍以及在风湿性疾病中使用药物 (葡萄皮质类药物,NSAIDs) 加快组织损伤并阻碍愈合.
- 在类风湿性疾病中,关节形和改变足部生物力学会增加机械应力,使病情恶化.
结论:
- 有效的管理需要采用多学科的方法,重点关注血糖控制,炎症调节,血管健康和预防性足部护理.
- 解决代谢 (糖尿病) 和类风湿病的因素对于预防慢性感染和截肢等严重并发症至关重要.
- 综合干预对于改善糖尿病足病和类风湿性疾病患者的临床结果和生活质量至关重要.
相关概念视频
Autoimmune Disorders
320
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
320
Diabetes: Management and Pharmacotherapy
212
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
212
Pathophysiology of Diabetes
813
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
813
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
101
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
101
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80


